These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24172116)

  • 1. Predictors of dropout in an outpatient treatment for problem drinkers including cognitive-behavioral therapy and the opioid antagonist naltrexone.
    Vuoristo-Myllys S; Lahti J; Alho H; Julkunen J
    J Stud Alcohol Drugs; 2013 Nov; 74(6):894-901. PubMed ID: 24172116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome predictors for problem drinkers treated with combined cognitive behavioral therapy and naltrexone.
    Vuoristo-Myllys S; Lipsanen J; Lahti J; Kalska H; Alho H
    Am J Drug Alcohol Abuse; 2014 Mar; 40(2):103-10. PubMed ID: 24456403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence.
    Anton RF; Moak DH; Latham P; Waid LR; Myrick H; Voronin K; Thevos A; Wang W; Woolson R
    J Clin Psychopharmacol; 2005 Aug; 25(4):349-57. PubMed ID: 16012278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence with naltrexone prescription advice in hospital outpatient alcohol rehabilitation programme.
    Feeney GF; Connor JP; Young RM; Tucker J; Czajkowski F
    J Clin Pharm Ther; 2001 Feb; 26(1):73-9. PubMed ID: 11286610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial.
    Anton RF; Moak DH; Waid LR; Latham PK; Malcolm RJ; Dias JK
    Am J Psychiatry; 1999 Nov; 156(11):1758-64. PubMed ID: 10553740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial.
    Heinälä P; Alho H; Kiianmaa K; Lönnqvist J; Kuoppasalmi K; Sinclair JD
    J Clin Psychopharmacol; 2001 Jun; 21(3):287-92. PubMed ID: 11386491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence.
    Balldin J; Berglund M; Borg S; Månsson M; Bendtsen P; Franck J; Gustafsson L; Halldin J; Nilsson LH; Stolt G; Willander A
    Alcohol Clin Exp Res; 2003 Jul; 27(7):1142-9. PubMed ID: 12878920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended naltrexone and broad spectrum treatment or motivational enhancement therapy.
    Longabaugh R; Wirtz PW; Gulliver SB; Davidson D
    Psychopharmacology (Berl); 2009 Oct; 206(3):367-76. PubMed ID: 19639303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of alcoholic beverage preference in the severity of alcohol dependence and adherence to the treatment.
    Baltieri DA; Daró FR; Ribeiro PL; De Andrade AG
    Alcohol; 2009 May; 43(3):185-95. PubMed ID: 19269773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, placebo-controlled study of sertraline with naltrexone for alcohol dependence.
    Farren CK; Scimeca M; Wu R; Malley SO
    Drug Alcohol Depend; 2009 Jan; 99(1-3):317-21. PubMed ID: 18644685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drinking behavior and motivation for treatment among alcohol-dependent liver transplant candidates.
    Weinrieb RM; Van Horn DH; McLellan AT; Volpicelli JR; Calarco JS; Lucey MR
    J Addict Dis; 2001; 20(2):105-19. PubMed ID: 11318394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: preliminary clinical evidence.
    Ait-Daoud N; Johnson BA; Prihoda TJ; Hargita ID
    Psychopharmacology (Berl); 2001 Feb; 154(1):23-7. PubMed ID: 11292002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of dropout in concurrent treatment of posttraumatic stress disorder and alcohol dependence: Rate of improvement matters.
    Zandberg LJ; Rosenfield D; Alpert E; McLean CP; Foa EB
    Behav Res Ther; 2016 May; 80():1-9. PubMed ID: 26972745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naltrexone, relapse prevention, and supportive therapy with alcoholics: an analysis of patient treatment matching.
    Jaffe AJ; Rounsaville B; Chang G; Schottenfeld RS; Meyer RE; O'Malley SS
    J Consult Clin Psychol; 1996 Oct; 64(5):1044-53. PubMed ID: 8916634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence.
    Pettinati HM; Kampman KM; Lynch KG; Suh JJ; Dackis CA; Oslin DW; O'Brien CP
    J Subst Abuse Treat; 2008 Jun; 34(4):378-90. PubMed ID: 17664051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted naltrexone treatment of early problem drinkers.
    Kranzler HR; Tennen H; Penta C; Bohn MJ
    Addict Behav; 1997; 22(3):431-6. PubMed ID: 9183513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia.
    Petrakis IL; O'Malley S; Rounsaville B; Poling J; McHugh-Strong C; Krystal JH;
    Psychopharmacology (Berl); 2004 Mar; 172(3):291-7. PubMed ID: 14634716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naltrexone treatment for opioid dependence: does its effectiveness depend on testing the blockade?
    Sullivan MA; Bisaga A; Mariani JJ; Glass A; Levin FR; Comer SD; Nunes EV
    Drug Alcohol Depend; 2013 Nov; 133(1):80-5. PubMed ID: 23827259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid antagonists in the treatment of alcohol dependence: clinical efficacy and prevention of relapse.
    O'Malley SS
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():77-81. PubMed ID: 8737005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial.
    Garbutt JC; Kranzler HR; O'Malley SS; Gastfriend DR; Pettinati HM; Silverman BL; Loewy JW; Ehrich EW;
    JAMA; 2005 Apr; 293(13):1617-25. PubMed ID: 15811981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.